In power distribution systems, three-phase transformer configuration directly impacts system reliability and load management. Understanding the trade-offs between Delta and Wye connections enables ...
With a phase 3 win for a combination of its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) and Keytruda, Merck & Co.’s partner Kelun-Biotech is the latest to claim that ...
Score another one for amyloid immunotherapy. The anti-pyroglutamated amyloid antibody donanemab has posted positive top-line results in the Phase 3 Trailblazer-Alz2 study, according to an Eli Lilly ...
Palvella Therapeutics completed a Phase 3 trial for QTORIN™ rapamycin, targeting a rare genetic disease, with results expected in 2026. Top-line results from the SELVA trial are expected in the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback